ArticleCancers2020

Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized Trial.

Henrik Suttmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.